Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $26.99 USD
Change Today +0.03 / 0.11%
Volume 94.6K
ITCI On Other Exchanges
As of 10:03 AM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sharon Mates Ph.D.

Co-Founder, Chairman, Chief Executive Officer and President,Intra-Cellular Therapies, Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Sharon Mates, Ph.D. Co-founded Intra-Cellular Therapies, Inc. in August 2013 and has been its President and Chief Executive Officer since August 2013. Dr. Mates established and managed a small business, where she served as a Research Analyst and Investment Banker in San Francisco. From 1989 to 1998, he served as the President of North American Vaccine and its predecessor companies. Dr. Mates co-founded Functional Genetics, Inc. and served as its Chairman and Chief ...

Read Full Background

Corporate Headquarters*

430 East 29th Street
New York, New York 10016

United States

Phone: 212-923-3344
Fax: --

Board Members Memberships*

Co-Founder, Chairman, Chief Executive Officer and President


The Ohio State University
PhD 1981
University of Washington
Master's Degree
Harvard Medical School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$954,000

Stock Options*

All Other Compensation$8,592
Exercised Options50,000
Exercised Options Value$724,500
Exercisable Options387,490
Unexercisable Options150,010
Total Value of Options$724,500
Total Number of Options587,500

Total Compensation*

Total Annual Cash Compensation$962,592
Total Short Term Compensation$954,000
Other Long Term Compensation$8,592
Total Calculated Compensation$3,362,752
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ITCI:US $26.99 USD +0.03


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTRA-CELLULAR THERAPIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at